EW, K., OP, B., MK, G., RB, D., S, E., EJ, B., . . . GG, K. (2012). Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood. Clinical chemistry, 58(3), 599. https://doi.org/10.1373/clinchem.2011.171637
Chicago Style (17th ed.) CitationEW, Klee, Bondar OP, Goodmanson MK, Dyer RB, Erdogan S, Bergstralh EJ, Bergen HR 3rd, Sebo TJ, and Klee GG. "Candidate Serum Biomarkers for Prostate Adenocarcinoma Identified by MRNA Differences in Prostate Tissue and Verified with Protein Measurements in Tissue and Blood." Clinical Chemistry 58, no. 3 (2012): 599. https://doi.org/10.1373/clinchem.2011.171637.
MLA (9th ed.) CitationEW, Klee, et al. "Candidate Serum Biomarkers for Prostate Adenocarcinoma Identified by MRNA Differences in Prostate Tissue and Verified with Protein Measurements in Tissue and Blood." Clinical Chemistry, vol. 58, no. 3, 2012, p. 599, https://doi.org/10.1373/clinchem.2011.171637.
